2018
DOI: 10.1002/mnfr.201701057
|View full text |Cite
|
Sign up to set email alerts
|

The Oral Bioavailability of Trans‐Resveratrol from a Grapevine‐Shoot Extract in Healthy Humans is Significantly Increased by Micellar Solubilization

Abstract: The oral bioavailability of trans-resveratrol from the grapevine-shoot extract Vineatrol30 was significantly increased using a liquid micellar formulation, without any treatment-related adverse effects, making it a suitable system for improved supplementation of trans-resveratrol.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
34
1
1

Year Published

2018
2018
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 58 publications
(40 citation statements)
references
References 34 publications
1
34
1
1
Order By: Relevance
“…Thus the two issues of resveratrol bioavailability and resistance exercise protocol should be examined further in order to understand their combinational benefits and mechanisms. The oral bioavailability of resveratrol in humans is quite limited, but may be increased significantly without any treatment-related adverse effects through the use of a liquid micellar formulation [ 39 ]. The dose in current animal studies could be further converted to human dose according to the conversion factor of 12.3-fold by body surface area difference, suggested by US Food and Drug Administration [ 40 ].…”
Section: Discussionmentioning
confidence: 99%
“…Thus the two issues of resveratrol bioavailability and resistance exercise protocol should be examined further in order to understand their combinational benefits and mechanisms. The oral bioavailability of resveratrol in humans is quite limited, but may be increased significantly without any treatment-related adverse effects through the use of a liquid micellar formulation [ 39 ]. The dose in current animal studies could be further converted to human dose according to the conversion factor of 12.3-fold by body surface area difference, suggested by US Food and Drug Administration [ 40 ].…”
Section: Discussionmentioning
confidence: 99%
“…These include several delivery systems such as the encapsulation of RES in lipid nanocarriers or liposomes, emulsions, micelles, insertion into polymeric nanoparticles, solid dispersions, and nanocrystals [59,60]. For example, the bioavailability of RES from the grapevine shoot extract Vineatrol30 has been significantly increased using a liquid micellar formulation, without any treatment-related adverse effects, making it a suitable system for improved supplementation [61]. On the other hand, the bioavailability of RES delivered through oral mucosa may be significantly higher than by swallowing, as determined by the fraction of the initial RES intake in the blood and, under metabolized form, in the urine [62].…”
Section: Bioavailability Of Resveratrol and Potential Side Effectsmentioning
confidence: 99%
“…To date, several formulation strategies such as amorphous solid dispersions, composite nanoparticles, emulsions, liposomes, polymeric micelles, self-emulsifying drug delivery systems, and solid lipid nanoparticles have been investigated to resolve this problem [10][11][12][13][14][15][16][17][18][19]. In addition, the enhanced oral bioavailability in humans has been reported with lipid formulation, micellar liquid formulation, and microparticles mixed with a liquid formulation [20][21][22]. Previously, the area under the plasma concentration versus time curve (AUC) and maximum plasma concentration (C max ) values obtained after oral administration at a dose of 40-mg trans-resveratrol were approximately 10-fold and 8.5-fold higher in the capsule containing solubilized resveratrol in polysorbate 20 and polyglyceryl-3-dioleate mixture than in powder capsule (original powder), respectively [20].…”
Section: Introductionmentioning
confidence: 99%
“…Previously, the area under the plasma concentration versus time curve (AUC) and maximum plasma concentration (C max ) values obtained after oral administration at a dose of 40-mg trans-resveratrol were approximately 10-fold and 8.5-fold higher in the capsule containing solubilized resveratrol in polysorbate 20 and polyglyceryl-3-dioleate mixture than in powder capsule (original powder), respectively [20]. In a case study using capsules containing solubilized resveratrol in polysorbate 80, polysorbate 20, and medium chain triacylglycerol mixtures, the intake of a liquid micellar formulation containing 30 mg trans-resveratrol produced higher AUC (5.0-fold increase) and C max (10.6-fold increase) than the equivalent dose of the original powder [21]. In a human pharmacokinetic study using a suspension prepared by mixing resveratrol powder and the liquid formulation (docusate sodium solution and distilled water) at a daily dose of 5.0 g trans-resveratrol, the oral bioavailability of the micronized powder (particle size less than 5 µm) was significantly higher than that of the nonmicronized powder, with approximately 3.6-fold increases in the C max values at 14 days [22].…”
Section: Introductionmentioning
confidence: 99%